Corvus Pharmaceuticals, Inc. Gains 38.25%

Tue, Sep 21, 2021 at 05:33 PM
Corvus Pharmaceuticals, Inc. Gains 38.25%

Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) jumped higher at $8.53, a gain of 38.2%. On Mon, Sep 20, 2021, CRVS:NASDAQ touched a New 2-Week High of $6.17. The stock appeared on our News Catalysts scanner on Sun, Sep 19, 2021 at 12:03 PM in the 'BIOTECH' category. From Tue, Sep 07, 2021, the stock recorded 55.56% Up Days and 40.00% Green Days

About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.